ISRCTN ISRCTN50082383
DOI https://doi.org/10.1186/ISRCTN50082383
Secondary identifying numbers A092044 version 1.1
Submission date
05/04/2011
Registration date
06/09/2011
Last edited
23/11/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
There is an international shortage of kidneys for transplantation, and there is great interest in optimising the kidneys available, in order to ensure that kidney transplants last for as long as possible with the best long-term function. When kidneys are recovered from deceased donors they inevitably face a period of storage while they are shipped to the recipient hospital and the logistics of transplantation are put into place. It has been shown that this period of storage can be harmful to kidneys and so this study aims to test which of two commonly used storage techniques is best for kidney transplant outcome. The first technique is 'cold static storage' in which the kidney is placed in cold preservation solution and transported in a box of ice. The second is 'cold pulsatile machine perfusion' in which the kidney is placed on a machine that pumps preservation fluid around the kidney.

Who can participate?
Adult recipients of kidney transplants.

What does the study involve?
Kidneys for transplant will be randomly allocated to either be placed upon the pulsatile perfusion machine or placed in a standard cold-storage ice-box. The kidney transplant recipients will be asked if their information may be followed up.

What are the possible benefits and risks of participating?
Both kidney storage techniques are commonly used in clinical practice outside the study, and we do not anticipate any additional risks from taking part in the study over the standard risks of transplantation but, as many patients will require further transplants, the information gained from this study may help them in future.

Where is the study run from?
The study is being run from Cambridge, with patients from Leeds, Manchester, Edinburgh and Glasgow also taking part.

When is the study starting and how long is it expected to run for?
From April 2011 to May 2017.

Who is funding the study?
NHS Blood and Transplant (UK).

Who is the main contact?
Professor Chris Watson

Contact information

Prof Chris Watson
Scientific

Department of Surgery
Box 202
Addenbrooke's Hospital
Hill's Road
Cambridge
CB2 0QQ
United Kingdom

Study information

Study designMulticentre randomised controlled study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA multicentre randomised controlled study of machine perfusion on cardiac death donor kidneys
Study acronymCAD-MP
Study objectivesCold pulsatile machine perfusion reduces the incidence of delayed graft function in cardiac-death donor kidneys for transplantation, when compared to simple cold storage.

On 26/06/2015 the overall trial end date was changed from 06/08/2012 to 01/12/2016.
Ethics approval(s)National Research Ethics Service, Cambridgeshire 2 Research Ethics Committee, 08/03/2011, ref: 11/H0308/3
Health condition(s) or problem(s) studiedKidney transplantion
InterventionOne kidney will be placed upon the LifePort pulsatile perfusion machine. The other will be placed in standard cold-storage ice-box
Intervention typeProcedure/Surgery
Primary outcome measureDelayed graft function - the need for dialysis within the first week following transplantation
Secondary outcome measures1. Duration of delayed graft function
2. The area under the curve of the daily serum creatinine level at days 1 to 14
3. Day 14 calculated estimated Glomerular Filtration Rate (eGFR) [abbreviated Modified Diet in Renal Disease (MDRD) technique]
4. The need for dialysis in the first 7 days excluding the first 24 hours post transplant
5. Median times to last dialysis
6. Non-graft function rates, defined as a kidney transplant that fails to provide one month of dialysis free renal replacement, where loss is not attributable directly to rejection or vascular thrombosis
7. Incidence of acute rejection
8. Three and twelve month graft survival
9. Three and twelve month serum creatinine
10. Three and twelve month glomerular filtration rate (MDRD method18)
11. Incidence of graft loss for technical reasons, e.g. renal artery or vein thrombosis
12. One year patient survival
13. Length of hospital stay
Overall study start date06/04/2011
Completion date31/05/2017

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsSequential trial design - maximum of 270 recipients
Key inclusion criteria1. Patients who receive a kidney transplant from a controlled or uncontrolled cardiac-death deceased donor
2. Recipient over the age of 18
Key exclusion criteria1. Lack of informed consent
2. Positive crossmatch
3. Previous recipient of non-kidney solid-organ transplant
Date of first enrolment06/04/2011
Date of final enrolment01/12/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Addenbrooke's Hospital
Cambridge
CB2 0QQ
United Kingdom

Sponsor information

Cambridge University Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Research And Development Department
Box 277
Addenbrooke's Hospital
Hill's Road
Cambridge
CB2 0QQ
England
United Kingdom

Phone +44 (0)12 2334 9321 ext 59321
Email julie.taylor@addenbrookes.nhs.uk
Website http://www.cuh.org.uk/
ROR logo "ROR" https://ror.org/04v54gj93

Funders

Funder type

Government

NHS Blood and Transplant (UK) (ref: UKT07/2)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planTo be confirmed at a later date
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Basic results 23/11/2018 23/11/2018 No No

Additional files

ISRCTN50082383_BasicResults_23Nov18.pdf
Uploaded 23/11/2018

Editorial Notes

23/11/2018: The basic results of this trial have been uploaded as an additional file.
18/12/2017: The overall trial end date was updated from 01/12/2016 to 31/05/2017.